IPCA LABORATORIES

BSE: 524494 30 Sep 2025

Healthcare

₹ 1345.5

Ipca Laboratories Ltd. specializes in Pharmaceuticals within the Healthcare sector.

IPCA LABORATORIES

BSE: 524494 30 Sep 2025

Healthcare

₹ 1345.5

Ipca Laboratories Ltd. specializes in Pharmaceuticals within the Healthcare sector.

Book Value

274.0

Dividend Yield

0.29%

Debt to Equity

0.2

Stock P/E

38.9

Market Cap

34,788 Cr

IPCA LABORATORIES - Share Price & Details

Market Cap

₹34,788

High /Low

1,758 / 1,168

Stock P/E

38.9

Book Value

₹274.0

Dividend Yield

0.29

ROCE

14.7

ROE

₹12.8

Face Value

1.0

PEG Ratio

-26.3

EVEBITDA

₹19.3

Debt

1,363

CMP / FCF

72.4

Debt to equity

₹0.2

NP Ann

785

High price all time

1,758

Piotroski score

₹9.0

Graham Number

435.0

No. Eq. Shares

25.4

Net CF

₹169

Net profit

819

Price to book value

5.01

Interest Coverage

₹18.3

Low price all time

23.5

Industry PE

33.0

Reserves

₹6,923

Free Cash Flow

₹551

Broker Recommendations

Date	Author	Type	Reco Price	Target Price	Potential	Source	PDF Link
13 Aug 2025	Prabhudas Lilladher	Buy	₹1,376.3	₹1,525	11.7%	moneycontrol	View
31 May 2025	Prabhudas Lilladher	Buy	₹1,423.95	₹1,525	7.7%	moneycontrol	View
14 Feb 2025	Prabhudas Lilladher	Buy	₹1,461.8	₹1,700	16.1%	moneycontrol	View
27 Dec 2024	Motilal Oswal	Buy	₹1,630.55	₹1,980	19%	moneycontrol	View
14 Nov 2024	Sharekhan	Buy	₹1,536.95	₹1,765	16.3%	moneycontrol	View
14 Oct 2024	Motilal Oswal	Buy	₹1,681.05	₹1,950	28.4%	moneycontrol	View
30 Sep 2024	Sharekhan	Buy	₹1,496.7	₹1,734	14.2%	moneycontrol	View
15 Aug 2024	Prabhudas Lilladher	Sell	₹1,350.7	₹1,250	-17.5%	moneycontrol	View
14 Aug 2024	Motilal Oswal	Hold	₹1,350.7	₹1,310	-13.6%	moneycontrol	View
14 Aug 2024	Sharekhan	Buy	₹1,350.7	₹1,600	5.5%	moneycontrol	View
03 Jun 2024	Sharekhan	Buy	₹1,126.9	₹1,350	-10.1%	moneycontrol	View
31 May 2024	Prabhudas Lilladher	Buy	₹1,152.1	₹1,150	-23.4%	moneycontrol	View
15 Feb 2024	Motilal Oswal	Hold	₹1,151.3	₹1,080	-28.1%	moneycontrol	View

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
FABINO ENTERPRISES LIMITED	NA	NA	NA	NA	5.09	84.8
Triochem Products Ltd.,	NA	NA	NA	NA	0
IPCA LABORATORIES LTD.	17719.2	2620.4	17469.0	10.33	34,788	38.9
Cohance Lifesciences Limited	4966.8	525.7	4835.8	1.37	33257	94.6
Aster DM Healthcare Limited	6514.7	805.9	6130.4	1.57	32388	91.6

Peer Comparison Chart

About IPCA LABORATORIES

Ipca Laboratories Ltd., with Security Code 524494, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.

Order Book

Latest News

Decline in pharma stocks today due to Trump tariff is largely ‘sentimental’ | Business News

(27 Sep 2025)

While Sun Pharma, the heaviest stock on Nifty Pharma, fell as much as 5%, Laurus Labs declined the most—about 6%.

Deals, Drugs, And Disruption: Glenmark, Lupin, IPCA Labs And Others Lead India's Pharma Opportunity Boom

(25 Sep 2025)

At a time when Indian markets have ranked among the worst performers in the world over the past 12 months, the pharma sector is witnessing a...

Ipca teams with BioSimilar Sciences PR LLC

(25 Sep 2025)

Ipca Laboratories and BioSimilar Sciences PR LLC (BSS) today announced a definitive Technology Transfer and Joint Development Agreement that...

Deals, Drugs, And Disruption: Glenmark, Lupin, IPCA Labs And Others Lead Indias Pharma Opportunity Boom

(25 Sep 2025)

At a time when Indian markets have ranked among the worst performers in the world over the past 12 months, the pharma sector is witnessing a...

Ipca Labs to license cancer, autoimmune disorder drug to US firm BSS

(24 Sep 2025)

Drug firm Ipca Laboratories Ltd on Wednesday (September 24) announced that it has signed a definitive technology transfer and joint...

Ipca Labs share price falls 3.35%, among top losers on Nifty Midcap 150

(22 Sep 2025)

Shares of Ipca Labs declined by 3.35%, trading at Rs 1392.70 on Monday. The stock is among the top losers on the Nifty Midcap 150 index.

Quarterly Table

Standalone Consolidated

Metrics	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Sales	1,401.6	1,488.7	1,662.7	1,506.8	1,510.6	1,565.9	1,810.9	1,662.7	1,638.4	1,746.9
Expenses	1,226.0	1,191.2	1,353.7	1,233.3	1,218.3	1,212.6	1,408.8	1,251.6	1,279.8	1,340.0
Operating Profit	175.6	297.5	309.0	273.5	292.3	353.2	402.1	411.1	358.6	406.9
OPM %	12.53%	19.99%	18.58%	18.15%	19.35%	22.56%	22.2%	24.72%	21.89%	23.29%
Other Income	33.5	43.2	36.1	16.9	-79.2	15.4	17.0	17.4	-260.1	25.0
Interest	17.7	30.8	38.6	27.2	24.1	19.4	17.3	10.2	16.2	12.1
Depreciation	59.2	60.4	61.4	63.0	61.8	61.3	62.7	62.8	65.2	63.1
Profit before tax	132.2	249.6	245.1	200.2	221.6	287.9	339.2	355.5	298.7	356.8
Tax %	-35.8%	-33.3%	-33.9%	-31.6%	-49.1%	-29.1%	-28%	-24.7%	-479.3%	26.5%
Net Profit	84.8	166.6	162.1	136.9	64.8	204.1	244.1	267.6	-65.1	262.0
EPS in Rs	3.34	6.57	6.39	5.4	2.55	8.05	9.62	10.55	0	10.33

Metrics	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	1,546.0	1,511.6	1,587.6	2,034.0	2,052.9	2,033.0	2,092.6	2,354.9	2,245.4	2,246.7
Expenses	1,336.0	1,333.5	1,282.1	1,713.6	1,723.2	1,712.7	1,699.9	1,913.4	1,783.3	1,819.6
Operating Profit	210.0	178.1	305.5	320.3	329.7	320.3	392.7	441.5	462.1	427.1
OPM %	13.58%	11.78%	19.24%	15.75%	16.06%	15.76%	18.77%	18.75%	20.58%	19.01%
Other Income	30.9	36.4	44.9	38.6	90.5	-117.8	20.6	26.3	20.1	-179.2
Interest	10.8	18.5	31.4	44.1	33.4	29.4	24.1	22.6	16.8	21.5
Depreciation	66.6	69.5	69.3	90.3	99.5	98.1	98.9	100.4	98.5	100.1
Profit before tax	163.5	126.5	249.7	224.4	219.2	211.7	290.4	344.8	367.0	331.3
Tax %	-31.7%	-37.4%	-34%	-39%	-22.9%	-96.2%	-31.5%	-28.8%	-24.6%	-48.6%
Net Profit	109.7	78.1	164.1	136.5	221.0	1.3	199.1	245.8	276.4	64.0
EPS in Rs	4.25	3.02	6.42	5.72	7.09	2.35	7.58	9.05	9.78	0

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	7%
5 Years:	11%
3 Years:	6%
TTM:	8%

Compounded Profit Growth
10 Years:	2%
5 Years:	6%
3 Years:	-19%
TTM:	44%

Stock Price CAGR
10 Years:	16%
5 Years:	13%
3 Years:	15%
1 Year:	10%

Compounded Sales Growth
10 Years:	9%
5 Years:	15%
3 Years:	12%
TTM:	21%

Compounded Profit Growth
10 Years:	2%
5 Years:	5%
3 Years:	-21%
TTM:	37%

Stock Price CAGR
10 Years:	16%
5 Years:	13%
3 Years:	15%
1 Year:	10%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

Stock Mutual Funds Data

Order Book

News Date ▲▼	Headline ▲▼	Issuer Entity ▲▼	Issuer Type ▲▼	Order Size ▲▼	Time Period ▲▼
Loading company updates…

Loading technicals…

Moving Averages

Latest Close: — • Records Used: — • Last Trading Date: —

Simple Moving Averages (SMA)

Period	SMA Value	Status

Exponential Moving Averages (EMA)

Period	EMA Value	Status

Oscillators

Key Oscillators

latest calculation

Indicator	Value

IPCA LABORATORIES

IPCA LABORATORIES

IPCA LABORATORIES - Share Price & Details

Broker Recommendations

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About IPCA LABORATORIES

Order Book

Latest News

Decline in pharma stocks today due to Trump tariff is largely ‘sentimental’ | Business News

Deals, Drugs, And Disruption: Glenmark, Lupin, IPCA Labs And Others Lead India's Pharma Opportunity Boom

Ipca teams with BioSimilar Sciences PR LLC

Deals, Drugs, And Disruption: Glenmark, Lupin, IPCA Labs And Others Lead Indias Pharma Opportunity Boom

Ipca Labs to license cancer, autoimmune disorder drug to US firm BSS

Ipca Labs share price falls 3.35%, among top losers on Nifty Midcap 150

If EPS Growth Is Important To You, Ipca Laboratories (NSE:IPCALAB) Presents An Opportunity

The Ipca Laboratories Limited (NSE:IPCALAB) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Ipca Laboratories Ltd (BOM:524494) Q1 2026 Earnings Call Highlights: Strong Growth Amidst ... By GuruFocus

Q1 Result Updates: Titagarh Rail Systems Profit Falls 54%; Som Distilleries Revenue Rises 3%

Ipca Labs Q1 PAT climbs 21% YoY to Rs 233 cr

Q1 results today: Bata, Ipca Labs, Muthoot Microfin among 287 on Aug 11

Bajaj Consumer Care, Bata, IPCA Laboratories, Astral Q1 Results Today — Earnings Estimates

IPCA Labs Q1 Results: Profit up 21% YoY, exports buoy growth despite margin dip

Q1 results next week: Vodafone Idea, ONGC, BPCL, Ashok Leyland; check full list

Ipca Laboratories Ltd (IPCALAB) Share Price

21 Dividend Stocks: Hyundai Motor, Berger Paints, Alembic, Ipca Labs — Last Day To Buy Shares To Qualify

Ipca Laboratories shares fall over 2% in morning trade; stock among top losers on Nifty Midcap 150

Stocks to buy or sell: Osho Krishan of Angel One suggests buying Exide, Ipca Laboratories shares today - 31 July

Ipca Laboratories shares jump 2.73% amid high volume in today's session

Ipca Laboratories schedules board meeting

Stocks to buy: Rajesh Palviya of Axis Sec suggests Jindal Steel, Ipca Lab, Rain Industries shares today - 25 July

Volumes soar at Ipca Laboratories Ltd counter

Ipca Laboratories Ltd soars 1.02%, rises for third straight session

Ipca Laboratories to hold AGM

Ipca Laboratories Ltd spurts 0.19%, up for five straight sessions

Ipca Laboratories (NSE:IPCALAB) Will Pay A Dividend Of ₹2.00

EU court upholds EUR 13.96 mn fine on Ipca Labs subsidiaries

Ipca Laboratories' (NSE:IPCALAB) Dividend Will Be ₹2.00

Ipca Labs appoints Dr Nagaji Ambabhai Vekariya as President - CRD

Ipca Laboratories Ltd soars 1.25%, Gains for third straight session

Dr Reddys Laboratories Ltd up for third consecutive session

Pharma Stocks to Buy: Brokerage bullish on Sun Pharma, Dr Reddy's Labs, IPCA Labs; note down targets

Board of Ipca Laboratories recommends final dividend

Ipca Laboratories Limited Just Missed Earnings - But Analysts Have Updated Their Models

IPCA Labs Q4 Results: Revenue and margin grow from last year; dividend announced

BOARD OF IPCA LABORATORIES RECOMMENDS FINAL DIVIDEND

Ipca Laboratories Says Consolidated Net Profit Hikes 14% To ₹68 Crore, Revenue From Operations Rises To

Ipca Laboratories Q4 Results: Net profit rises 14% to ₹68 crore; final dividend declared

Ipca Laboratories Limited (NSE:IPCALAB) Not Lagging Market On Growth Or Pricing

Pharma News: Pharma Industry News, Pharmaceutical Company News Updates

Ipca Laboratories now holds 100% stake in Unichem Laboratories, Ireland

IPCA LABORATORIES NOW HOLDS 100PERCENT STAKE IN UNICHEM LABORATORIES IRELAND

Cipla, Sun Pharma, Ipca Labs, JB Pharma drive Indian pharma market growth in March’2025

Pharma stocks decline up to 3%; Biocon, IPCA, Granules, Natco Pharma top losers

Pharma stocks decline up to 7%; Biocon, IPCA, Granules, Natco Pharma top losers

Pharma stocks slide up to 7% as Trump hints at unprecedented tariffs on sector

Tariff fear grips pharma sector as index tanks over 4.5%: IPCA, Laurus, Aurobindo, Lupin top losers

Pharma stocks crack up to 10% as Trump warns of 'never seen before' tariffs

Pharma stocks including Cipla, Dr Reddys, Biocon, Divis, Ipca crash 6% amid Trump’s tariff blow

Indian Pharma Stocks Highlights: Ipca Laboratories, Lupin, Sun Pharma and Cipla lead gainers surging over 4%, Trump’s tariff exemption boosts investor sentiment

No chill, just pills! Pharma stocks slide up to 8% as Trump does yes-no-yes on tariff

F&O Strategy: Buy Balrampur Chini, V-Guard and Ipca Lab, suggests Rupak De in a weak stock market today - 1 April 2025

Stock market update: Nifty Pharma index advances 0.53% in an upbeat market

Ipca Laboratories Ltd down for fifth straight session

Natco Pharma, Orchid Pharma, NBCC India, IPCA Labs: Stock price targets

IPCA Laboratories share price jumps 7% after healthy Q3 results; details

IPCA Laboratories shares gain 7% as net profit jumps 38% to Rs 248 crore

IPCA Labs Q3 Results: Shares rise 6% as net profit jumps 38%; margin expands from last year

IPCA Labs to Launch Maharashtra's First Fully Green Pharma Plant in Wardha

IPCA Labs Stock Trades Near Days High As Company Reports 39% Increase In Q3 Net Profit

Former Amitabh Bacchan company, to start 100% green pharma company in Wardha

Former Amitabh Bacchan company, to start 100% green pharma company in Wardha | Nagpur News

IPCA Labs & Coforge: Turnaround stories with over 2o% upside potential

Ipca Laboratories Ltd spurts 0.49%, rises for fifth straight session

Buy Auro Pharma & IPCA Labs; sell BHEL: Religare shares maiden weekly calls for 2025

Ipca Laboratories Ltd soars 1.49%, rises for third straight session

Buy Ipca Laboratories, target price Rs 1,980: Motilal Oswal Financial Services

Stocks To Buy: Axis Direct recommends buying SBI Life Insurance, Glenmark Pharma, 4 other stocks for 2 weeks; check targets